Skip to content
Search

Latest Stories

TECHNOLOGY: Building back smarter

Gary Paragpuri says community pharmacists can outsmart their online rivals by making smallscale adjustments within their businesses to differentiate their pharmacy offering…

I was contacted by an experienced contractor from a busy London pharmacy who was interested in purchasing a Pharmaself24. Our discussion was anchored on the features and benefits of the product, but we enjoyed a far-reaching conversation about the past, present and future of pharmacy.


On hanging up the phone, I was struck by the clarity of this individual’s vision for what they wanted their pharmacy to become. It was clear their interest in a Pharmaself24 was not about buying a machine in isolation, but about investing in a key component that forms part of a bigger plan.

It was about shaping a new type of pharmacy offering fit for the exacting and varied expectations of patients today, tomorrow and long into the future.

Challenges ahead

There is much to admire when speaking to people like this, particularly when you look at the cold, hard facts. The NPA commissioned report produced by EY in September 2020 illuminated just how difficult today’s pharmacy landscape has become from a financial perspective.

It estimates that the sector is under-funded to the tune of £497m, adding that 72 per cent of pharmacies are projected to be loss-making within four years based on the current contractual arrangements.

By 2024 the average pharmacy, claims the report, will be making an annual loss of £43k – a situation that EY’s health economics director, George Agathangelou, described as “unsustainable” and requiring “urgent attention”.

The accuracy of the exact figures involved may be cause for debate, but the broader picture is one that many contractors recognise. As a result, a significant number of pharmacy owners have found themselves contemplating their choices, with a startling 52 per cent reported to be considering selling up altogether.

pic for Gary Pharmacy needs to find a new direction

Decision time

Chair of the All-Party Pharmacy Group Jackie Doyle-Price MP said the report shows how pharmacies are at a crossroads. Without being pedantic, it is perhaps more akin to the sector approaching a traffic jam on the motorway, with a certain inevitability about blindly continuing down the path ahead.

Making a variety of small-scale adjustments within a business may provide answers to some of the questions posed in the report. This approach is encapsulated within the ‘marginal gains’ theory that propelled the Team Sky cycling juggernaut to unparalleled success.

There is, however, a growing body of thought that the most significant factor behind Sky’s achievements was not, in fact, the little wins, but rather the fact that it had a gargantuan budget – double that of its rivals.

This meant it could afford to recruit the best athletes and the top support staff.

Returning to the motorway analogy, marginal gains for some pharmacy businesses may therefore be seen as the equivalent of switching lanes in the traffic jam, consuming time and effort but unlikely to deliver the hoped-for rewards.

The alternative is to look beyond the marginal – to take decisive action, find a new direction, seek out a clearer way forward – but committing to such a manoeuvre is no small undertaking. It relies on identifying the crucial issues at play and implementing the right measures to resolve them.

Is managing resource the key?

One such issue is how to balance resourcing levels. A study carried out by printing firm Brother in 2019, discussed in a recent Pharmacy Business article, shows that increasing workloads associated with the delivery of new services are negatively impacting pharmacy teams’ stress levels and mental health.

At the same time, figures contained within the EY/NPA report show that as many as 87 per cent of pharmacies say they can’t afford to take on more staff.

Another issue is working out how to grow prescription levels – the bedrock of pharmacy income. The threat from local competitors upping their game as well as the continued rise of online pharmacies mean it’s more important than ever to find ways of differentiating your offering in a way that satisfies your patient community.

These are not issues that will go away. And while it is understandably more comfortable to continue bumping along the same familiar road, the only way to really tackle them head on is by defining a clear vision for your pharmacy business and then translating that into a plan of action.

A vision for the community

The London contractor I mentioned at the top of this article has done exactly that, as did Zia Ashraf, owner of HMI Pharmacy in Kirkham – one of our first Pharmaself24 customers in England.

Facing the prospect of a decline in prescription income as a result of local surgeries moving away, Zia decided to galvanise the business around a vision of becoming his community’s 24-hour medicine collection hub.

Following the installation of a Pharmaself24 – and with excellent marketing – his prescription numbers have skyrocketed and all without the need for additional resource. A truly stunning achievement.

Talking with the London contractor and hearing them speak passionately about how they were going to achieve their vision was invigorating. Perhaps that’s the start – find the people in your network and beyond who are walking the walk and see what you can learn. From there you can find, hone and begin to action your own vision, making 2021 the year you build back smarter.

Gary Paragpuri is CEO of Hub and Spoke Innovations.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less